Deferred Tax Assets, Operating Loss Carryforwards in USD of ABVC BIOPHARMA, INC. from Q3 2011 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Abvc Biopharma, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and change rate from Q3 2011 to Q3 2025.
- Abvc Biopharma, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending September 30, 2025 was $6M.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)